Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases
Abstract Mesenchymal stem cell (MSC) therapies have been used in clinical trials in various fields. These cells are easily expanded, show low immunogenicity, can be acquired from medical waste, and have multiple functions, suggesting their potential applications in a variety of diseases, including l...
Saved in:
Main Authors: | Atsunori Tsuchiya (Author), Yuichi Kojima (Author), Shunzo Ikarashi (Author), Satoshi Seino (Author), Yusuke Watanabe (Author), Yuzo Kawata (Author), Shuji Terai (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2017-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mesenchymal stem cell therapies for liver cirrhosis: MSCs as "conducting cells" for improvement of liver fibrosis and regeneration
by: Atsunori Tsuchiya, et al.
Published: (2019) -
Transition of clinical and basic studies on liver cirrhosis treatment using cells to seek the best treatment
by: Shuji Terai, et al.
Published: (2021) -
Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases
by: Atsunori Tsuchiya, et al.
Published: (2020) -
Optimization of transplantation methods using isolated mesenchymal stem/stromal cells: clinical trials of inflammatory bowel diseases as an example
by: Daisuke Hisamatsu, et al.
Published: (2024) -
Mesenchymal Stem Cell-derived Exosomes: Novel Therapeutic Approach for Inflammatory Bowel Diseases
by: Cheng-mei Tian, et al.
Published: (2023)